Intensive urate-lowering with pegloticase plus methotrexate co-therapy in uncontrolled gout patients with and without chronic kidney disease: A retrospective case series.
Journal Information
Full Title: Medicine (Baltimore)
Abbreviation: Medicine (Baltimore)
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"We thank Qianhong Fu, MS, employee of and stockholder in Horizon (now Amgen, Inc.), for statistical consultation. We thank Qianhong Fu, MS, employee of and stockholder in Horizon (now Amgen, Inc.), for statistical consultation. John Albert and Aaron Broadwell are speakers for and consultants to Horizon (now Amgen, Inc.). Lissa Padnick-Silver, Brad Marder, and Brian LaMoreaux are employees of and stockholders in Horizon (now Amgen, Inc.)."
"Funding acquisition: Brian LaMoreaux. These analyses were funded by Horizon Therapeutics plc (now Amgen, Inc.). Authors affiliated with the study sponsor were involved in study design, data analysis and interpretation, and manuscript development."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025